Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet (Unaudited)

v3.20.2
Condensed Balance Sheet (Unaudited)
Sep. 30, 2020
USD ($)
ASSETS  
Current asset - cash $ 25,000
Deferred offering costs 244,067
TOTAL ASSETS 269,067
Current liabilities  
Accrued offering costs 740
Promissory note – related party 246,702
Total Current Liabilities 247,442
Commitments
Stockholder’s Equity  
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 3,162,500 shares issued and outstanding 316 [1]
Additional paid-in capital 24,684
Accumulated deficit (3,375)
Total Stockholder’s Equity 21,625
TOTAL LIABILITIES AND STOCKHOLDER’S EQUITY $ 269,067
[1] Includes an aggregate of up to 412,500 shares of common stock subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On October 20, 2020, the Company effectuated a stock dividend of 0.1 share for each share of its common stock outstanding, resulting in an aggregate of 3,162,500 Founder Shares outstanding (see Note 5).